Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway

Endometrial cancer is one of the most common malignancy affecting women in developed countries. Resection uterus or lesion area is usually the first option for a simple and efficient therapy. Therefore, it is necessary to find a new therapeutic drug to reduce surgery areas to preserve fertility. Ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chia-Hung, Weng, Tzu-Hsiang, Huang, Kai-Yao, Kao, Hui-Ju, Liao, Kuang-Wen, Weng, Shun-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724248/
https://www.ncbi.nlm.nih.gov/pubmed/36483599
http://dx.doi.org/10.7150/ijms.78349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724248/
https://www.ncbi.nlm.nih.gov/pubmed/36483599
http://dx.doi.org/10.7150/ijms.78349

Ejemplares similares